Heparin/heparan sulphate binding in the TGF-β cytokine superfamily

The TGF-β (transforming growth factor-β) cytokine superfamily in mammals contains some 30 members. These dimeric proteins are characterized by a strongly conserved cystine knot-based structure. They regulate the proliferation, differentiation and migration of many cell types, and therefore have important roles in morphogenesis, organogenesis, tissue maintenance and wound healing. Thus far, around one-quarter of these cytokines have been shown to bind to heparin and heparan sulphate. Well-established examples are the TGF-β isoforms 1 and 2, and the BMPs (bone morphogenetic proteins) -2 and -4. In studies in my laboratory, we have shown that GDNF (glial-cell-line-derived neurotrophic factor) and its close relatives neurturin and artemin bind to heparin and heparan sulphate with high affinity. We have reported previously that binding of GDNF is highly dependent on the presence of 2-O-sulphate groups. More recently, we and others have been investigating the heparin/heparan sulphate-binding properties of BMP-7, which is a representative of a distinct BMP subgroup from that of BMPs -2 and -4. Interestingly, several of the various specific BMP antagonist proteins also bind to heparin and heparan sulphate. Much remains to be learnt about the nature and role of glycosaminoglycan interactions in the TGF-β superfamily, but current work suggests that these cytokines do not share a single highly conserved heparin/heparan sulphate-binding site.

[1]  W. N. Pappano,et al.  Cell-surface Heparan Sulfate Proteoglycans Potentiate Chordin Antagonism of Bone Morphogenetic Protein Signaling and Are Necessary for Cellular Uptake of Chordin* , 2004, Journal of Biological Chemistry.

[2]  Xinhua Lin,et al.  Drosophila Dpp Morphogen Movement Is Independent of Dynamin-Mediated Endocytosis but Regulated by the Glypican Members of Heparan Sulfate Proteoglycans , 2004, Cell.

[3]  John A Latham,et al.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist , 2003, The EMBO journal.

[4]  R. Kamijo,et al.  Sulfated Polysaccharides Enhance the Biological Activities of Bone Morphogenetic Proteins* , 2003, Journal of Biological Chemistry.

[5]  C. Innis,et al.  Crystal Structures of the Heparan Sulfate-binding Domain of Follistatin , 2003, Journal of Biological Chemistry.

[6]  A. Irie,et al.  Heparan sulfate is required for bone morphogenetic protein-7 signaling. , 2003, Biochemical and biophysical research communications.

[7]  J. Turnbull,et al.  Structural Determinants of Heparan Sulphate Modulation of GDNF Signalling , 2003, Growth factors.

[8]  R. Mummery,et al.  The binding of human glial cell line-derived neurotrophic factor to heparin and heparan sulfate: importance of 2-O-sulfate groups and effect on its interaction with its receptor, GFRalpha1. , 2003, Glycobiology.

[9]  C. Rider Interaction between glial-cell-line-derived neurotrophic factor (GDNF) and 2-O-sulphated heparin-related glycosaminoglycans. , 2003, Biochemical Society transactions.

[10]  T. Jardetzky,et al.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF‐β ligand:receptor interactions , 2003, The EMBO journal.

[11]  V. Wilson,et al.  Role of heparan sulfate-2-O-sulfotransferase in the mouse. , 2002, Biochimica et biophysica acta.

[12]  Markus Affolter,et al.  Structural basis of BMP signalling inhibition by the cystine knot protein Noggin , 2002, Nature.

[13]  M. Barnett,et al.  Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan , 2002, Journal of Cell Science.

[14]  Naoto Ueno,et al.  Action Range of BMP Is Defined by Its N-Terminal Basic Amino Acid Core , 2002, Current Biology.

[15]  A. Economides,et al.  Heparan Sulfate Proteoglycans Retain Noggin at the Cell Surface , 2002, The Journal of Biological Chemistry.

[16]  M. Affolter,et al.  Biochemical and Biophysical Characterization of RefoldedDrosophila DPP, a Homolog of Bone Morphogenetic Proteins 2 and 4* , 1998, The Journal of Biological Chemistry.

[17]  R. Beddington,et al.  Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. , 1998, Genes & development.

[18]  M. Lyon,et al.  The Interaction of the Transforming Growth Factor-βs with Heparin/Heparan Sulfate Is Isoform-specific* , 1997, The Journal of Biological Chemistry.

[19]  M. Grütter,et al.  The crystal structure of TGF‐β3 and comparison to TGF‐β2: Implications for receptor binding , 1996, Protein science : a publication of the Protein Society.

[20]  W. Sebald,et al.  Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. , 1996, European journal of biochemistry.

[21]  D. L. Griffith,et al.  Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  H. Fox Growth and degeneration of the pronephric system of Rana temporaria. , 1962, Journal of embryology and experimental morphology.

[23]  O. Avsian-Kretchmer,et al.  Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists. , 2004, Molecular endocrinology.